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The life-expectancy of cancer patients has been extended with advances 
in therapy (De Vita et al 1979). As a consequence, Health Care 
Professionals face an increasing population of cancer patients whose 
primary need is to maintain an optimal quality of life. The chief 
complaint of many terminal cancer patients is pain. Although 
pharmacological, anaesthesiological, surgical and oncological techniques 
for the relief of pain are nowadays available, reports from USA as well 
as from Europe (Bonica 1986, Darrepaal et al 1989) indicate a severe 
undertteatment of cancer pain. 
Effective pain management is one of the four priorities in a 
comprehensive WHO cancer programme, the others being primary 
prevention, early detection and treatment of curable cancers (WHO 1986). 
High priority is placed on improving the knowledge of pain treatment in 
terminal illness among physician's, nurses and pharmacists. For more 
effective education, information is needed about the present situation in 
the treatment of cancer pain. 
In Malta, no information is available yet, on the prevalence of pain in 
cancer patients, nor on the current status of pain treatment. In order to 
assess the quality of pain control and terminal care of cancer patients in 
this country, three studies were therefore carried out. In one study, 
interviews were conducted to cancer patients in hospital. Two 
questionnaire studies were also carried out, one directed to ,physicians and 
the other to relatives of cancer patients who died in Maltese hospitals. 
Methods 
Study 1:. Patient Interviews 
60 consecutive patients admitted to the cancer wards of Sir Paul Boffa 
Hospital were screened for pain complaints. Twenty seven patients 
reported being in pain at the time of the interview. Of these, 6 were 
induded)n the' pilot stage of the research. The remaining 21 patients 
represented the final study sample. The interview protocol covered the 
foHowing topics: (1) pain intensity and pattern; (2) the effect of pain on 
daily activities, sleep and mood state; (3) factors influencing the pain 
experience; (4) the use and perceived effectiveness of analgesics. Each 
week during a patients stay in the hospital, a short version of the 
interview was conducted. Additionally, 2 physicians experienced in the 
treatment of cancer pain were asked to rate the adequacy of the pain 
therapy and to provide suggestions for change in those cases where the 
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pain management was considered to be inadequate. The raters were 
provided with the necessary information from the medical records and 
the patient interviews on which to base their judgements. 
study 2: Questionnaire Survey among Maltese physicians 
A questionnaire concerning current practice and experiences in the 
treatment of cancer pain was sent to 200 physicians. This study was based 
on the replies from 84 physicians who stated that they at least 
sometimes see cancer patients. Three simulated patient cases were 
presented in the questionnaire, and the adequacy of the treatment 
suggestions were evaluated. The physicians' view on the role of the 
medical authorities, the problems experienced in pain treatment, their 
opinion about drug abuse and side effects, and the influence of basic and 
postgraduate education were requested. 
Study 3: Questionnaire Survey among Relatives of Cancer Patients who 
died in Maltese Hospitals 
. 
In order to evaluate the quality of pain treatment, terminal care and 
psychological support in Malta, a questionnaire was sent to the closest 
relatives, as defined by the hospital routine, of 250 cancer patients, who 
died in hospital during 1990. The names and addresses of the nearest 
relatives were obtained from the patient's case records, which were 
selected by diagnosis from the hospital's yearly statistics. The study is 
based on the replies from 140 family members. The questionnaire 
consisted of 21 multi-choice questions. After the questions, the 
respondents were asked to freely express their comments and suggestions 
regarding the case of a dying patient in a hospital. 
Results 
Study 1: Patient Interviews 
Of the 60 hospitalised cancer patients screened, 27 (45%) were found to be 
in pain. Although 57% of these patients had found ways to reduce their 
pain, nearly one third reported being seriously limited in their daily 
activities. Sleep disorder and mood disturbance also were related to the 
experience of pain. Applied pain, management strategies were rated by 
the 2 physicians as inadequate in 52% of the cases. The most frequent 
recommendations for improved pain management was an increase in the 
dosage or a change in the class of analgesics. 
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Study 2: Questionnaire Survey among Maltese physicians 
The results of the questionnaire study addressed to physicians indicate 
that drugs predominate in the treatment of cancer pain in Malta. 
However, only half of the physicians reached the criteria of correct use 
of analgesics for chronic pain in terms of daily doses and dose intervals. 
The mean daily doses of opioids prescribed for severe cancer pain were 
equivalent to 24 and 39 mg of intramuscular morphine in 2 of the 3 
simulated patient cases. These doses represent one third and one half of 
effective daily doses, respectively. 
According to the physicians themselves, the factors which mainly 
determined the current practice in pain treatment were the physician's 
own clinical experience, post-graduate education and the example of 
colleagues. Most respondents, however, told that they see cancer patients 
only occassionally. Thus, the possibility of getting feedback from their 
own treatment is small. 
According to the physicians, the most frequent problems in the treatment 
of cancer pain was the ineffectiveness of the therapy. The side effects of 
drugs was the first-mentioned problem for 19% of the respondents. Drug 
dependence was seen by 27% of the physicians, but a detailed description 
of the problem revealed that in most cases, tolerance, withdrawal 
symptoms or undertreatment were called 'dependence'. 
Study 3: Questionnaire Survey among Relatives of Cancer Patients who 
died in Maltese Hospitals 
According to the relatives of the deceased patients, pain had been 
present in 74% of the cases. In most cases the pain had lasted for more 
than several months. The psychological support given to the patients 
and their families in hospital had been satisfactory in less than fifty per 
cent. In the free comments written by the family members about terminal 
care in hospital, the loneliness of the patient was the predominant 
theme. Poor pain treatment was complained of in 14% of the 95 free 
comments. 
Conclusions 
1. The overall prevalence of pain among hospitalised cancer patients 
appears to be 45% as determined from the patient interviews. Pain 
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managment during hospitalisation was judged to be inadequate in 
more than half of the evaluated cases. Furthermore, the results 
suggest that a broader ranger of treatment strategies need to be 
employed. These include nerve blocks, neurosurgical procedures and 
other potentially useful behavioural interventions. 
2. Cancer pain is undertreated in Malta. Physicians often use too 
weak analgesics in two small doses and with too long intervals. 
There is a need to reinforce the teaching and training of Maltese 
physicians and medical graduates in the principles of the 
treatment of cancer pain. 
3. The prevalence of pain among dying cancer patients seems to be 74% 
as indicated by the family members. The relatives of cancer 
patients think that the patients and their families do not get the 
psychological support they need. In the present situation, there are 
no resources to provide dying patients with care-giving personnel 
for a longer time than is required for routine physical and medical 
assitance. For better patient care, a change in the situation is 
urgently needed. 
Pharmacists can contribute to the struggle against cancer pain both 
in the community as well as in the hospital setting, and locally 
there is indication for extension of the role of the pharmacist in 
this field. 
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